FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Cesare Astori

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Irene Dambruoso; Ilaria Giardini; Barbara Rocca; Marianna Rossi; Patrizia Zappasodi; Rita Zappatore; Marina Boni; Celeste Calvello; Marilena Caresana; Carlo Castagnola; Paola Maria Cavigliano; Mario Cazzola; Cesare Astori; Paolo Bernasconi
Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome.
Francesca Novara; Luca Arcaini; Michele Merli; Francesco Passamonti; Silvia Zibellini; Silvia Rizzi; Sara Rattotti; Elisa Rumi; Cristiana Pascutto; Annalisa Vetro; Cesare Astori; Emanuela Boveri; Marco Lucioni; Marco Paulli; Orsetta Zuffardi; Mario Lazzarino
High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
Luca Arcaini; Silvia Zibellini; Francesco Passamonti; Sara Rattotti; Marco Lucioni; Rosangela Invernizzi; Michele Merli; Silvia Rizzi; Emanuela Boveri; Elisa Rumi; Cesare Astori; Cristina Picone; Marzia Varettoni; Cristiana Pascutto; Marco Paulli; Mario Lazzarino
Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Cesare Astori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Irene Dambruoso; Ilaria Giardini; Barbara Rocca; Marianna Rossi; Patrizia Zappasodi; Rita Zappatore; Marina Boni; Celeste Calvello; Marilena Caresana; Carlo Castagnola; Paola Maria Cavigliano; Mario Cazzola; Cesare Astori; Paolo Bernasconi
Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome.
Cancer genetics 2012;205(6):285-94.
2009: Francesca Novara; Luca Arcaini; Michele Merli; Francesco Passamonti; Silvia Zibellini; Silvia Rizzi; Sara Rattotti; Elisa Rumi; Cristiana Pascutto; Annalisa Vetro; Cesare Astori; Emanuela Boveri; Marco Lucioni; Marco Paulli; Orsetta Zuffardi; Mario Lazzarino
High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
Human pathology 2009;40(11):1628-37.
2009: Luca Arcaini; Silvia Zibellini; Francesco Passamonti; Sara Rattotti; Marco Lucioni; Rosangela Invernizzi; Michele Merli; Silvia Rizzi; Emanuela Boveri; Elisa Rumi; Cesare Astori; Cristina Picone; Marzia Varettoni; Cristiana Pascutto; Marco Paulli; Mario Lazzarino
Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
Blood cells, molecules & diseases 2009;42(3):286-91.
2009: Luca Arcaini; Cristiana Pascutto; Francesco Passamonti; RAFFAELE BRUNO; Michele Merli; Silvia Rizzi; Ester Orlandi; Cesare Astori; Sara Rattotti; Marco Paulli; Mario Lazzarino
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection.
International journal of cancer. Journal international du cancer 2009;124(9):2246-9.
2008: Francesco Passamonti; Elisa Rumi; Luca Arcaini; Emanuela Boveri; Chiara Elena; Daniela Pietra; Sabrina Boggi; Cesare Astori; Paolo Bernasconi; Marzia Varettoni; Ercole Brusamolino; Cristiana Pascutto; Mario Lazzarino
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.
Haematologica 2008;93(11):1645-51.
2008: Patrizia Zappasodi; Annamaria Nosari; Cesare Astori; Dennis Ciapanna; Maurizio Bonfichi; Marzia Varettoni; Silvia Mangiacavalli; Enrica Morra; Mario Lazzarino; Alessandro Corso
DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.
Transfusion 2008;48(5):857-60.
2007: Silvia Mangiacavalli; Patrizia Zappasodi; Carlo Castagnola; Cesare Astori; Marzia Varettoni; Mario Lazzarino; Alessandro Corso
Severe intestinal vasculitis in a patient under treatment with bortezomib.
Annals of hematology 2007;86(12):923-4.
2007: Patrizia Zappasodi; Roberto Dore; Carlo Castagnola; Cesare Astori; Marzia Varettoni; Silvia Mangiacavalli; Mario Lazzarino; Alessandro Corso
Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3380-1.
2006: Elisa Rumi; Francesco Passamonti; Emanuela Boveri; Mara De Amici; Cesare Astori; Marta Braschi; Carlo Castagnola; Umberto Magrini; Mario Cazzola; Mario Lazzarino
Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia.
American journal of hematology 2006;81(2):124-7.
2005: Alessandro Corso; Silvia Mangiacavalli; Annamaria Nosari; Carlo Castagnola; Patrizia Zappasodi; Anna Maria Cafro; Cesare Astori; Maurizio Bonfichi; Marzia Varettoni; Chiara Rusconi; Daniela Troletti; Cristiana Pascutto; Enrica Morra; Mario Lazzarino
Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma.
Bone marrow transplantation 2005;36(11):951-4.
2004: Elisa Rumi; Cesare Astori; A Casazza; Piero Marone; Maurizio Bonfichi
Peripheral intraneutrophil diplococci in a case of meningococcemia.
Haematologica 2004;89(4):EIM05.
2002: Paolo Bernasconi; Paola Maria Cavigliano; Marina Boni; Cesare Astori; Silvia Calatroni; Ilaria Giardini; Barbara Rocca; Marilena Caresana; Nicola Crosetto; Mario Lazzarino; Carlo Bernasconi
Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance.
British journal of haematology 2002;118(2):545-9.
2002: Francesco Passamonti; Lucia Malabarba; Ester Orlandi; Cristiana Pascutto; Ercole Brusamolino; Cesare Astori; Claudia Baratè; Angelo Canevari; Alessandro Corso; Paolo Bernasconi; Mario Cazzola; Mario Lazzarino
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.
British journal of haematology 2002;116(4):855-61.
2002: Alessandro Corso; Angela Lorenzi; Ester Orlandi; Cesare Astori; Silvia Mangiacavalli; Mario Lazzarino
Advantages of using thalidomide for the management of refractory myeloma patients.
Haematologica 2002;87(3):327-8.
2002: Mario Lazzarino; Luca Arcaini; Paolo Bernasconi; Emilio Paolo Alessandrino; Livio Gargantini; Roberto Cairoli; Ester Orlandi; Cesare Astori; Ercole Brusamolino; Guido Pagnucco; Anna A Colombo; Silvia Calatroni; Isabella Iacona; Mario Regazzi; Enrica Morra
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.
British journal of haematology 2002;116(1):229-35.
2001: Alessandro Corso; Luca Arcaini; Silvia Mangiacavalli; Cesare Astori; Ester Orlandi; Angela Lorenzi; Francesco Passamonti; Catherine Klersy; Cristiana Pascutto; A Canevari-Sciorati; Mario Lazzarino
Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.
Haematologica 2001;86(4):394-8.
2000: Paolo Bernasconi; Ester Orlandi; Paola Maria Cavigliano; Silvia Calatroni; Marina Boni; Cesare Astori; Guido Pagnucco; S Giglio; Marilena Caresana; Mario Lazzarino; Carlo Bernasconi
Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma.
Haematologica 2000;85(10):1087-91.
2000: Ercole Brusamolino; F Lunghi; Ester Orlandi; Cesare Astori; Francesco Passamonti; C Baraté; Guido Pagnucco; BAIO AMBROGIA; Pietro Franchini; Mario Lazzarino; Carlo Bernasconi
Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
Haematologica 2000;85(10):1032-9.
2000: Paolo Bernasconi; Cesare Astori; Paola Maria Cavigliano; Marina Boni; Luca Malcovati; Silvia Calatroni; Marilena Caresana; C Bernasoconi
Cytogenetic and FISH analyses in five patients with hypoplastic bone marrow.
Leukemia 2000;14(7):1322-3.
2000: Isabella Iacona; Mario Lazzarino; Maria Antonietta Avanzini; Maurizio Rupolo; Luca Arcaini; Cesare Astori; F Lunghi; Ester Orlandi; Enrica Morra; Vittorina Zagonel; Mario Regazzi
Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.
Therapeutic drug monitoring 2000;22(3):295-301.
2000: Paolo Bernasconi; Paola Maria Cavigliano; Marina Boni; Luca Malcovati; Cesare Astori; Carlo Castagnola; Guido Pagnucco; Laura Vanelli; Silvia Calatroni; Marilena Caresana; Mario Lazzarino; Carlo Bernasconi
Trisomy 11 and a complex t(11;11;22) in a patient with acute myelomonocytic leukemia (AML-M4) following myelodysplasia (MDS): a cytogenetic study of a mechanism of leukemogenesis.
Cancer genetics and cytogenetics 2000;116(2):111-8.
1999: Mario Lazzarino; Ester Orlandi; Fausto Baldanti; Milena Furione; Guido Pagnucco; Cesare Astori; Luca Arcaini; Alessandra Viglio; Marco Paulli; Giuseppe Gerna; Carlo Bernasconi
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders.
British journal of haematology 1999;107(4):877-82.
1999: Alessandro Corso; Cesare Astori; Ester Orlandi; Patrizia Zappasodi; Luca Arcaini; C Bernasconi
Transient response of myeloma clone to pamidronate therapy.
Haematologica 1999;84(8):759-60.
1999: Paolo Bernasconi; Paola Maria Cavigliano; Marina Boni; Luca Malcovati; Silvia Calatroni; Cesare Astori; Marilena Caresana; Carlo Bernasconi
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4)
Leukemia 1999;13(3):487-9.
1999: Mario Lazzarino; Ester Orlandi; M Montillo; A Tedeschi; Guido Pagnucco; Cesare Astori; Alessandro Corso; Ercole Brusamolino; Lavinia Simoncini; Enrica Morra; Carlo Bernasconi
Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):59-64.
1998: Paolo Bernasconi; Paola Maria Cavigliano; Emilia Genini; Carlo Castagnola; Luca Malcovati; Silvia Calatroni; Marilena Caresana; Marina Boni; Emilio Paolo Alessandrino; Cesare Astori; Alessandro Corso; Carlo Bernasconi
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome.
Cancer genetics and cytogenetics 1998;105(2):182-6.
1998: Ester Orlandi; M Lazzarino; P Bernasconi; Cesare Astori; C Bernasconi
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Haematologica 1998;83(8):758-9.
1998: Mario Lazzarino; Ester Orlandi; Catherine Klersy; Cesare Astori; Ercole Brusamolino; Alessandro Corso; L Bellio; Livio Gargantini; Enrica Morra; Carlo Bernasconi
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
Cancer 1998;82(3):576-82.
1997: Maurizio Bonfichi; Cesare Astori; Emilio Paolo Alessandrino; Paolo Bernasconi; Alessandra Balduini; Carlo Castagnola; Ercole Brusamolino; Guido Pagnucco; Angelo Canevari; P Trucco; Carlo Bernasconi
Growth factors in the therapy of myelodysplasia: biological aspects.
Leukemia & lymphoma 1997;26 Suppl 1():35-40.
1997: Paolo Bernasconi; Paola Maria Cavigliano; Emilia Genini; Emilio Paolo Alessandrino; A Colombo; Catherine Klersy; Luca Malcovati; G Biaggi; G Martinelli; Silvia Calatroni; Marilena Caresana; Marina Boni; Cesare Astori; Carlo Bernasconi
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse?
Leukemia 1997;11(11):1989-90.
1997: Ester Orlandi; M Lazzarino; Ercole Brusamolino; Marco Paulli; Cesare Astori; Umberto Magrini; C Bernasconi
Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence.
Leukemia & lymphoma 1997;26(3-4):359-68.
1997: Cesare Astori; Maurizio Bonfichi; Guido Pagnucco; Paolo Bernasconi; Mario Lazzarino; Ester Orlandi; Carlo Bernasconi
Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay.
British journal of haematology 1997;97(3):586-8.
1996: Mario Lazzarino; Ester Orlandi; Cesare Astori; Marco Paulli; Umberto Magrini; Carlo Bernasconi
A low serum beta 2-microglobulin level despite bulky tumor is a characteristic feature of primary mediastinal (thymic) large B-cell lymphoma: implications for serologic staging.
European journal of haematology 1996;57(4):331-3.
1996: Renato Rosso; A Castello; G Colosini; Cesare Astori; Mario Lazzarino; Umberto Magrini
Splenic marginal zone cell lymphoma involving liver and bone marrow. Report of a case with protracted follow-up, showing progressive disappearance of the lymphoma after splenectomy.
Haematologica 1996;81(1):44-6.
1995: Alessandro Corso; Mario Lazzarino; Enrica Morra; S Merante; Cesare Astori; Paolo Bernasconi; Marina Boni; Carlo Bernasconi
Chronic myelogenous leukemia and exposure to ionizing radiation--a retrospective study of 443 patients.
Annals of hematology 1995;70(2):79-82.
1995: Carlo Castagnola; Enrica Morra; Paolo Bernasconi; Cesare Astori; A Santagostino; Carlo Bernasconi
Acute myeloid leukemia and diabetes insipidus: results in 5 patients.
Acta haematologica 1995;93(1):1-4.
1994: Paolo Bernasconi; Emilio Paolo Alessandrino; Marina Boni; Maurizio Bonfichi; Enrica Morra; Mario Lazzarino; C Campagnoli; Cesare Astori
Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
American journal of hematology 1994;46(4):270-7.
1994: Ercole Brusamolino; Ester Orlandi; Angelo Canevari; Enrica Morra; G Castelli; Emilio Paolo Alessandrino; Guido Pagnucco; Paolo Bernasconi; Cesare Astori; Mario Lazzarino
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(5):427-32.
1994: Ercole Brusamolino; Ester Orlandi; Enrica Morra; G Castelli; Guido Pagnucco; A Livraghi; Cesare Astori; A Santagostino; Mario Lazzarino; Carlo Bernasconi
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():53-7.
1994: Ercole Brusamolino; Mario Lazzarino; Ester Orlandi; Angelo Canevari; Enrica Morra; G Castelli; Emilio Paolo Alessandrino; Guido Pagnucco; Cesare Astori; A Livraghi
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():101-6.
1993: Mario Lazzarino; Ester Orlandi; Marco Paulli; Emanuela Boveri; Enrica Morra; Ercole Brusamolino; S Kindl; Renato Rosso; Cesare Astori; M C Buonanno
Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2306-13.
1993: Paolo Bernasconi; Marina Boni; C Campagnoli; Cesare Astori; Emilio Paolo Alessandrino; Maurizio Bonfichi; Daniela Caldera; C Brera; D Troletti; G Biaggi
In situ hybridization to detect chimerism and the origin of relapse in sex-mismatched allogeneic bone marrow transplantation.
Bone marrow transplantation 1993;11 Suppl 1():84-7.